Crescent Biopharma Inc
F:C68
Crescent Biopharma Inc
F:C68
Price:
7.05
EUR
4.44%
Market Closed
Market Cap:
€97.9m
Relative Value
The Relative Value of one
C68
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 7.05 EUR,
Crescent Biopharma Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
C68 Relative Value
HIDDEN
Multiples Across Competitors
C68 Competitors Multiples
Crescent Biopharma Inc Competitors
Crescent Biopharma Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Crescent Biopharma Inc
F:C68
|
97.9m EUR | 0 | -2.8 | 0.9 | 0.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
403.2B USD | 6.8 | 171.9 | 16.6 | 23.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.6B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
189.4B USD | 6.4 | 22.3 | 15.1 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.8B USD | 10 | 30.3 | 23.2 | 24.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD | 5.8 | 18.5 | 14.1 | 16.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
73.9B AUD | 3.3 | 17.1 | 11.7 | 14.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.3B EUR | 14.4 | 33.9 | 58.2 | 59.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
